Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chandra Datta Sumi"'
Autor:
Puteri Juanita Zamri, Ms, Mohd-Hafiz Abdul-Aziz, Dr, Maria Patricia Hernandez-Mitre, Dr, Mohd Shahnaz Hasan, Associate Professor, Izyani Md Shariff, Dr, Helmi Sulaiman, Dr, Steve Wallis, Dr, Chandra Datta Sumi, Dr, Fekade Bruck Sime, Dr, Jason A Roberts, Professor
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 31, Iss , Pp S35-S36 (2022)
Externí odkaz:
https://doaj.org/article/141361253b394717822c9a63b25b34ed
Autor:
Md. Khalilur Rahman, Md. Ashraf Uddin Chowdhury, Mohammed Taufiqual Islam, Md. Anisuzzaman Chowdhury, Muhammad Erfan Uddin, Chandra Datta Sumi
Publikováno v:
Advances in Pharmacological Sciences, Vol 2015 (2015)
Diarrhea is one of the most common causes for thousands of deaths every year. Therefore, identification of new source of antidiarrheal drugs becomes one of the most prominent focuses in modern research. Our aim was to investigate the antidiarrheal an
Externí odkaz:
https://doaj.org/article/aa6cb9b90e8c47d6a559436125dc798d
Autor:
Md Jahidul Hasan, Chandra Datta Sumi, Shihan Mahmud Redwanul Huq, Ahmad Mursel Anam, Raihan Rabbani
Publikováno v:
The Journal of Critical Care Medicine. 9:106-115
Background Pandrug-resistant Klebsiella pneumoniae ventilator associated pneumonia (VAP) is associated with high rate of mortality in intensive care unit (ICU) and has been recognized as a difficult-to-treat infection worldwide. Polymyxin B or colist
Publikováno v:
Journal of Antimicrobial Chemotherapy. 78:854-857
Autor:
Chandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, Kyra Cottrell, Steven C Wallis, Jeffrey Lipman, Patrick N A Harris, Fekade B Sime, Jason A Roberts
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(11)
Objectives To compare the bacterial killing and emergence of resistance of intermittent versus prolonged (extended and continuous infusions) infusion dosing regimens of piperacillin/tazobactam against two Escherichia coli clinical isolates in a dynam
Autor:
Tomislav Mestrovic, Gisela Robles Aguilar, Lucien R Swetschinski, Kevin S Ikuta, Authia P Gray, Nicole Davis Weaver, Chieh Han, Eve E Wool, Anna Gershberg Hayoon, Simon I Hay, Christiane Dolecek, Benn Sartorius, Christopher J L Murray, Isaac Yeboah Addo, Bright Opoku Ahinkorah, Ayman Ahmed, Mamoon A Aldeyab, Kasim Allel, Robert Ancuceanu, Anayochukwu Edward Anyasodor, Marcel Ausloos, Fabio Barra, Akshaya Srikanth Bhagavathula, Dinesh Bhandari, Sonu Bhaskar, Natália Cruz-Martins, Anna Dastiridou, Klara Dokova, Eleonora Dubljanin, Oyewole Christopher Durojaiye, Adeniyi Francis Fagbamigbe, Simone Ferrero, Peter Andras Gaal, Veer Bala Gupta, Vijai Kumar Gupta, Vivek Kumar Gupta, Claudiu Herteliu, Salman Hussain, Irena M Ilic, Milena D Ilic, Elham Jamshidi, Tamas Joo, André Karch, Adnan Kisa, Sezer Kisa, Tomislav Kostyanev, Hmwe Hmwe Kyu, Judit Lám, Graciliana Lopes, Alexander G Mathioudakis, Alexios-Fotios A Mentis, Irmina Maria Michalek, Mohammad Ali Moni, Catrin E Moore, Francesk Mulita, Ionut Negoi, Ruxandra Irina Negoi, Tamás Palicz, Adrian Pana, João Perdigão, Ionela-Roxana Petcu, Navid Rabiee, David Laith Rawaf, Salman Rawaf, Murad Ziyaudinovich Shakhmardanov, Aziz Sheikh, Luís Manuel Lopes Rodrigues Silva, Valentin Yurievich Skryabin, Anna Aleksandrovna Skryabina, Bogdan Socea, Andy Stergachis, Temenuga Zhekova Stoeva, Chandra Datta Sumi, Arulmani Thiyagarajan, Marcos Roberto Tovani-Palone, Metin Yesiltepe, Sojib Bin Zaman, Mohsen Naghavi
Publikováno v:
2022, ' The burden of bacterial antimicrobial resistance in the WHO European region in 2019 : a cross-country systematic analysis ', The Lancet Public Health, vol. 7, no. 11, pp. e897-e913 . https://doi.org/10.1016/S2468-2667(22)00225-0
European Antimicrobial Resistance Collaborators 2022, ' The burden of bacterial antimicrobial resistance in the WHO European region in 2019 : a cross-country systematic analysis ', The Lancet Public Health, vol. 7, no. 11, pp. e897-e913 . https://doi.org/10.1016/S2468-2667(22)00225-0
European Antimicrobial Resistance Collaborators 2022, ' The burden of bacterial antimicrobial resistance in the WHO European region in 2019 : a cross-country systematic analysis ', The Lancet Public Health, vol. 7, no. 11, pp. e897-e913 . https://doi.org/10.1016/S2468-2667(22)00225-0
Funding: Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care using UK aid funding managed by the Fleming Fund. Background Antimicrobial resistance (AMR) represents one of the most crucial threats to public health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e22a5c706edbfc356f5d7c42c0bd32
https://edoc.unibas.ch/90459/
https://edoc.unibas.ch/90459/
Publikováno v:
Clinical Pharmacokinetics. 58:1407-1443
The rates of antibiotic resistance in Gram-negative bacteria are increasing. One method to minimize resistance emergence may be optimization of antibiotic dosing regimens to achieve drug exposure that suppress the emergence of resistance. The aim of
Autor:
Chandra Datta Sumi
Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales, e.g., Escherichia coli and Klebsiella pneumoniae can be severe and often deadly in critically-ill patients in intensive care units (ICUs). Achieving target antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91fbf34263500ab86bd99128a2200a29
https://doi.org/10.14264/uql.2020.871
https://doi.org/10.14264/uql.2020.871
Autor:
Kamrul Islam, Jason A. Roberts, Kyra Cottrell, Aaron J. Heffernan, Patrick N A Harris, Saiyuri Naicker, Chandra Datta Sumi, Fekade B. Sime
Publikováno v:
Access Microbiology. 2
Background - This study aims to compare the bacterial killing and suppression of resistance emergence of intermittent and prolonged infusions of piperacillin/tazobactam (PTZ) against clinical K. pneumoniae isolates. Methods - Two clinical isolates, C
Publikováno v:
Drug Delivery. 23:1-11
There is no doubt that controlled and pulsatile drug delivery system is an important challenge in medicine over the conventional drug delivery system in case of therapeutic efficacy. However, the conventional drug delivery systems often offer a limit